Drug Approval | February 19, 2022
Amneal expands injectables portfolio with four new products
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
The partnership will help digitize and automate existing tasks traditionally managed on paper, significantly reducing costs and lead times while increasing compliance
The newly enhanced drug development platform will help empower innovators with the fastest development timelines
With this approval, Brukinsa is now approved in 44 markets as BeiGene continues to advance its global registration, including the EU, US, and Great Britain
The device will facilitate the treatment of cerebral vasospasm following hemorrhagic stroke
TRIS AMINO HCl is widely used as a diagnostic reagent and as a downstream processing buffer in the purification of commercial biopharmaceuticals
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
Vonage Communications APIs allow developers to easily enhance and build intelligent, intuitive customer experiences directly into their existing applications and devices
Subscribe To Our Newsletter & Stay Updated
